Nehra, J.
Bradbury, P. A.
Ellis, P. M.
Laskin, J.
Kollmannsberger, C.
Hao, D.
Juergens, R. A.
Goss, G.
Wheatley-Price, P.
Hotte, S. J.
Gelmon, K.
Tinker, A. V.
Brown-Walker, P.
Gauthier, I.
Tu, D.
Song, X.
Khan, A.
Seymour, Lesley
Smoragiewicz, M.
Funding for this research was provided by:
Canadian Cancer Society Research Institute (704970)
Article History
Received: 12 December 2019
Accepted: 27 January 2020
First Online: 4 February 2020
Compliance with ethical standards
:
: Dr. J. Nehra: No conflicts of interest.Dr. P.A. Bradbury – Honoraria: Abbvie, Pfizer, Lilly, Merck. Advisory boards- Abbvie, BI.Dr. P.M. Ellis- Advisory Boards: AstraZeneca, Abbvie, Takeda, Pfizer. Honoraria for speaking for: AstraZeneca, Abbvie, Pfizer, Bristol-Myers Squibb.Dr. J. Laskin: honoraria/ad boards from Roche, BI, Takeda and AstraZeneca. My institution has received research funding from Roche, and AstraZeneca.Dr. C. Kollmannsberger – No conflicts of interest.Dr. D. Hao – Advisory Boards: AstraZeneca, Roche, Merck, Bristol Myers Squibb, Boehringer Ingelheim, Eli Lilly.Dr. R.A. Juergens – Advisory board, honoraria and grants: AstraZeneca, Bristol-Myers Squibb, Merck. Advisory board and honoraria: Amgen, Boehringer Ingelheim, Novartis, Roche, Pfizer, and Takeda.Dr. G. D. Goss reports Honoraria: AstraZeneca, BMS, IO Biotech. Travel reimbursement: Boehringer Ingelheim.Dr. P. Wheatley-Price – Advisory Boards: Takeda, Bristol-Myers Squibb, AstraZeneca, Merck, Abbvie, Roche.Dr. S. Hotte: Astra Zeneca: Research Funding (institution); honoraria/Advisory boards.Dr. K. Gelmon: Pharmaceutical Company Associations. Advisory Boards – AstraZeneca, Roche, Novartis, Pfizer, Oncotheryon, Nanostring, Merck, Mylan, Lilly, Genomic Health, Nanostring, BMS. Research Funding – Pfizer, Roche, AstraZeneca, Novartis, BMS. Expert Testimony - Genentech.Dr. A.V. Tinker: No conflicts of interest.Dr. P. Brown-Walker – No conflicts of interest.I. Gauthier: No conflicts of interest.Dr. D. Tu – No conflicts of interest.Dr. X. Song – Employee of AstraZeneca and owns stock in AstraZeneca.A. Khan: Employee of AstraZeneca and owns stock in AstraZeneca.Dr. L. Seymour – Received funds from AstraZeneca Pharmaceuticals on behalf of CCTG to support the conduct of the trial. Owns stock in AstraZeneca.Dr. M. Smoragiewicz – No conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.